help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Graham, C. H.
Right arrow Articles by White, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graham, C. H.
Right arrow Articles by White, W. L.

American Journal of Pathology, Vol 145, 510-514, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas

CH Graham, J Rivers, RS Kerbel, KS Stankiewicz and WL White
Cancer Research Division, Sunnybrook Health Science Centre, Reichmann Research Institute, Toronto, Ontario, Canada.

Angiogenesis in malignant melanoma (MM) was evaluated by comparing mean vessel number (MVN) in Spitz's nevi (SN), thick and thin MMs that metastasized, and thick and thin MMs with > or = 10-year survival. Vessels were identified with antibodies against factor VIII-related antigen (FVIII) and CD34 in 37 MMs (17 < or = 1.9 mm and 20 > or = 4.0 mm) with > or = 10-year follow-up and 10 SN from children (< or = 9 years old). Fields (x250) with the highest vessel density were counted by independent observers blinded to clinical outcome. There were no differences in MVN between SN versus MMs (P = 1.0), but the distribution of vessels was much more uniform in SN. Seven MM pairs (> or = 5.5 mm) and five pairs (< or = 0.75 mm) were matched by sex, age, site, stage, and primary treatment (paired t-test). In the pairs > or = 5.5 mm, there was no correlation with MVN with either metastasis or death (FVIII P = 0.98; CD34 P = 0.85). Among the thin paired lesions, high MVN (FVIII = 46, CD34 = 39) was significantly related not only to metastasis (FVIII P = 0.04, CD34 P = 0.03) but also to death (FVIII P = 0.04, CD34 P = 0.05). MVN does not separate SN versus MM nor predict outcome in thick (> or = 4.0 mm) MMs; however, high MVN (> or = 42 average) is predictive of metastasis and death in MMs < or = 0.75 mm. Larger matched studies are indicated to confirm this observation.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
R. T. P. Poon, C. Lau, R. Pang, K. K. Ng, J. Yuen, and S. T. Fan
High Serum Vascular Endothelial Growth Factor Levels Predict Poor Prognosis after Radiofrequency Ablation of Hepatocellular Carcinoma: Importance of Tumor Biomarker in Ablative Therapies
Ann. Surg. Oncol., June 1, 2007; 14(6): 1835 - 1845.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
O. Lucidarme, Y. Kono, J. Corbeil, S.-H. Choi, J.-L. Golmard, J. Varner, and R. F. Mattrey
Angiogenesis: Noninvasive Quantitative Assessment with Contrast-enhanced Functional US in Murine Model.
Radiology, June 1, 2006; 239(3): 730 - 739.
[Abstract] [Full Text] [PDF]

Home page
 Integr Cancer TherHome page
D. R. Yance Jr and S. M. Sagar
Targeting angiogenesis with integrative cancer therapies.
Integr Cancer Ther, March 1, 2006; 5(1): 9 - 29.
[Abstract] [PDF]

Home page
 JCOHome page
R. J. Bleicher, R. Essner, L. J. Foshag, L. A. Wanek, and D. L. Morton
Role of Sentinel Lymphadenectomy in Thin Invasive Cutaneous Melanomas
J. Clin. Oncol., April 1, 2003; 21(7): 1326 - 1331.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Tripodis and P. Demant
Genetic Analysis of Three-dimensional Shape of Mouse Lung Tumors Reveals Eight Lung Tumor Shape-Determining (Ltsd) Loci That Are Associated with Tumor Heterogeneity and Symmetry
Cancer Res., January 1, 2003; 63(1): 125 - 131.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. I. Cline, S. Bicciato, C. DiBello, and M. W. Lingen
Prediction of in Vivo Synergistic Activity of Antiangiogenic Compounds by Gene Expression Profiling
Cancer Res., December 15, 2002; 62(24): 7143 - 7148.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L. Hlatky, P. Hahnfeldt, and J. Folkman
Clinical Application of Antiangiogenic Therapy: Microvessel Density, What It Does and Doesn't Tell Us
J Natl Cancer Inst, June 19, 2002; 94(12): 883 - 893.
[Full Text] [PDF]

Home page
 IOVSHome page
R. Clarijs, I. Otte-Holler, D. J. Ruiter, and R. M. W. de Waal
Presence of a Fluid-Conducting Meshwork in Xenografted Cutaneous and Primary Human Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 912 - 918.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. T.-P. Poon, I. O.-L. Ng, C. Lau, W.-C. Yu, Z.-F. Yang, S.-T. Fan, and J. Wong
Tumor Microvessel Density as a Predictor of Recurrence After Resection of Hepatocellular Carcinoma: A Prospective Study
J. Clin. Oncol., April 1, 2002; 20(7): 1775 - 1785.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. L. Yu, J. W. Rak, G. Klement, and R. S. Kerbel
Vascular Endothelial Growth Factor Isoform Expression as a Determinant of Blood Vessel Patterning in Human Melanoma Xenografts
Cancer Res., March 1, 2002; 62(6): 1838 - 1846.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
O. Straume and L. A. Akslen
Importance of Vascular Phenotype by Basic Fibroblast Growth Factor, and Influence of the Angiogenic Factors Basic Fibroblast Growth Factor/Fibroblast Growth Factor Receptor-1 and Ephrin-A1/EphA2 on Melanoma Progression
Am. J. Pathol., March 1, 2002; 160(3): 1009 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 Cell Growth Differ.Home page
K. Satyamoorthy, G. Li, B. Vaidya, J. Kalabis, and M. Herlyn
Insulin-like Growth Factor-I-induced Migration of Melanoma Cells Is Mediated by Interleukin-8 Induction
Cell Growth Differ., February 1, 2002; 13(2): 87 - 93.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
O. Straume and L. A. Akslen
Expresson of Vascular Endothelial Growth Factor, Its Receptors (FLT-1, KDR) and TSP-1 Related to Microvessel Density and Patient Outcome in Vertical Growth Phase Melanomas
Am. J. Pathol., July 1, 2001; 159(1): 223 - 235.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. Clarijs, L. Schalkwijk, D. J. Ruiter, and R. M. W. de Waal
Lack of Lymphangiogenesis Despite Coexpression of VEGF-C and Its Receptor Flt-4 in Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1422 - 1428.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. R. Hess, E. A. Seftor, L. M. G. Gardner, K. Carles-Kinch, G. B. Schneider, R. E. B. Seftor, M. S. Kinch, and M. J. C. Hendrix
Molecular Regulation of Tumor Cell Vasculogenic Mimicry by Tyrosine Phosphorylation: Role of Epithelial Cell Kinase (Eck/EphA2)
Cancer Res., April 1, 2001; 61(8): 3250 - 3255.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
G. L. Beatty and Y. Paterson
IFN-{{gamma}}-Dependent Inhibition of Tumor Angiogenesis by Tumor-Infiltrating CD4+ T Cells Requires Tumor Responsiveness to IFN-{{gamma}}
J. Immunol., February 15, 2001; 166(4): 2276 - 2282.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Ugurel, G. Rappl, W. Tilgen, and U. Reinhold
Increased Serum Concentration of Angiogenic Factors in Malignant Melanoma Patients Correlates With Tumor Progression and Survival
J. Clin. Oncol., January 15, 2001; 19(2): 577 - 583.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Aguayo, H. Kantarjian, T. Manshouri, C. Gidel, E. Estey, D. Thomas, C. Koller, Z. Estrov, S. O'Brien, M. Keating, et al.
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
Blood, September 15, 2000; 96(6): 2240 - 2245.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. K. Rofstad and E. F. Halsør
Vascular Endothelial Growth Factor, Interleukin 8, Platelet-derived Endothelial Cell Growth Factor, and Basic Fibroblast Growth Factor Promote Angiogenesis and Metastasis in Human Melanoma Xenografts
Cancer Res., September 1, 2000; 60(17): 4932 - 4938.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
T. Etoh, K. Shibuta, G. F. Barnard, S. Kitano, and M. Mori
Angiogenin Expression in Human Colorectal Cancer: The Role of Focal Macrophage Infiltration
Clin. Cancer Res., September 1, 2000; 6(9): 3545 - 3551.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
H. Kuniyasu, P. Troncoso, D. Johnston, C. D. Bucana, E. Tahara, I. J. Fidler, and C. A. Pettaway
Relative Expression of Type IV Collagenase, E-cadherin, and Vascular Endothelial Growth Factor/Vascular Permeability Factor in Prostatectomy Specimens Distinguishes Organ-confined from Pathologically Advanced Prostate Cancers
Clin. Cancer Res., June 1, 2000; 6(6): 2295 - 2308.
[Abstract] [Full Text]

Home page
 The OncologistHome page
H.M. Pinedo and D. J. Slamon
INTRODUCTION: Translational Research: The Role of VEGF in Tumor Angiogenesis
Oncologist, April 1, 2000; 5(90001): 1 - 2.
[Full Text]

Home page
 Am. J. Pathol.Home page
R. Folberg, M. J. C. Hendrix, and A. J. Maniotis
Vasculogenic Mimicry and Tumor Angiogenesis
Am. J. Pathol., February 1, 2000; 156(2): 361 - 381.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Kunz, A. Hartmann, E. Flory, A. Toksoy, D. Koczan, H.-J. Thiesen, N. Mukaida, M. Neumann, U. R. Rapp, E.-B. Brocker, et al.
Anoxia-Induced Up-Regulation of Interleukin-8 in Human Malignant Melanoma : A Potential Mechanism for High Tumor Aggressiveness
Am. J. Pathol., September 1, 1999; 155(3): 753 - 763.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.